PRESENTATION

Q2 FY2023 — Presentation

Q2 FY2023PDF · 17 pages803 KB
Fiscal Year 2023, Second Quarter
October 28, 2022
EARNINGS CALL
PRESENTATION

-- 1 of 17 --

2
HORACIO ROZANSKI
President and Chief Executive Officer
MATT CALDERONE
Chief Financial Officer
NATHAN RUTLEDGE
Director & Head of Investor Relations
CALL
PARTICIPANTS

-- 2 of 17 --

3
DISCLAIMER
Forward Looking Safe Harbor Statement
Certain statements contained in this presentation and in related comments by our management include “forward-looking statements” within the meaning of the Private Securities
Litigation Reform Act of 1995. Examples of forward-looking statements include information concerning Booz Allen’s preliminary financial results, financial outlook and guidance, including
forecasted revenue, Adjusted EBITDA, Diluted EPS, Adjusted Diluted EPS, future quarterly dividends, and future improvements in operating margins, as well as any other statement that
does not directly relate to any historical or current fact. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “could,” “should,” “forecasts,”
“expects,” “intends,” “plans,” “anticipates,” “projects,” “outlook,” “believes,” “estimates,” “predicts,” “potential,” “continue,” “preliminary,” or the negative of these terms or other
comparable terminology. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we can give you no assurance these expectations will
prove to have been correct.
These forward-looking statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our
actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these
forward-looking statements. A number of important factors could cause actual results to differ materially from those contained in or implied by these forward-looking statements,
including those factors discussed in our filings with the Securities and Exchange Commission (SEC), including our Annual Report on Form 10-K for the fiscal year ended March 31, 2022,
which can be found at the SEC’s website at www.sec.gov. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the
foregoing cautionary statements. All such statements speak only as of the date made and, except as required by law, we undertake no obligation to update or revise publicly any forward-
looking statements, whether as a result of new information, future events or otherwise.
Note Regarding Non-GAAP Financial Data Information
Booz Allen discloses Revenue, Excluding Billable Expenses, Adjusted Operating Income, Adjusted EBITDA, Adjusted EBITDA Margin on Revenue, Adjusted EBITDA Margin on Revenue,
Excluding Billable Expenses, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow, Free Cash Flow Conversion, and Net Leverage Ratio, which are not recognized measurements
under accounting principles generally accepted in the United States, or GAAP, and when analyzing Booz Allen’s performance or liquidity as applicable, investors should (i) evaluate each
adjustment in our reconciliation of revenue to Revenue, Excluding Billable Expenses, operating income to Adjusted Operating Income, net income attributable to common stockholders to
Adjusted EBITDA, Adjusted EBITDA Margin on Revenue, Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses, Adjusted Net Income and Adjusted Diluted EPS, and net cash
used in operating activities to Free Cash Flow and Free Cash Flow Conversion, and net debt to Net Leverage Ratio and the explanatory footnotes regarding those adjustments, each as
defined under GAAP, (ii) use Revenue, Excluding Billable Expenses, Adjusted Operating Income, Adjusted EBITDA, Adjusted EBITDA Margin on Revenue, Adjusted EBITDA Margin on
Revenue Excluding Billable Expenses, Adjusted Net Income, and Adjusted Diluted EPS in addition to, and not as an alternative to, revenue, operating income, net income attributable to
common stockholders or diluted EPS as measures of operating results, each as defined under GAAP, (iii) use Free Cash Flow, Free Cash Flow Conversion, and Net Leverage Ratio, in
addition to, and not as an alternative to, net cash used in operating activities as a measure of liquidity, each as defined under GAAP, and (iv) use Net Leverage Ratio in addition to, and not
as an alternative to, net debt as a measure of Booz Allen's debt leverage. The Appendix includes a reconciliation of Revenue, Excluding Billable Expenses, Adjusted Operating Income,
Adjusted EBITDA, Adjusted EBITDA Margin on Revenue, Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow, Free
Cash Flow Conversion, and Net Leverage Ratio to the most directly comparable financial measure calculated and presented in accordance with GAAP. Booz Allen presents these
supplemental performance measures because it believes that these measures provide investors and securities analysts with important supplemental information with which to evaluate
Booz Allen’s performance, long term earnings potential, or liquidity, as applicable, and to enable them to assess Booz Allen’s performance on the same basis as management. These
supplemental performance and liquidity measurements may vary from and may not be comparable to similarly titled measures by other companies in Booz Allen’s industry. With respect
to our expectations under “Financial Outlook”, "Fiscal Year 2023 Operating Cash Bridge" and "Fiscal Year 2023 ADEPS Bridge," reconciliation of Adjusted Diluted EPS guidance, Adjusted
EBITDA, and Adjusted EBITDA Margin on Revenue to the closest corresponding GAAP measure is not available without unreasonable efforts on a forward-looking basis due to our inability
to predict our stock price, equity grants and dividend declarations with respect to Adjusted Diluted EPS, and our net income, net interest and other expenses with respect to Adjusted
EBITDA and Adjusted EBITDA Margin on Revenue, during the course of fiscal 2023. With respect to Adjusted Diluted EPS guidance, projecting future stock price, equity grants and
dividends to be declared would be necessary to accurately calculate the difference between Adjusted Diluted EPS and GAAP EPS as a result of the effects of the two-class method and
related possible dilution used in the calculation of EPS. Consequently, any attempt to disclose such reconciliation would imply a degree of precision that could be confusing or misleading
to investors. We expect the variability of the above charges to have an unpredictable, and potentially significant, impact on our future GAAP financial results. For the same reason, a
reconciliation of Adjusted EBITDA and Adjusted EBITDA Margin on Revenue guidance for fiscal 2023 and 2025 and of Adjusted EBITDA guidance through fiscal 2025 to the closest
corresponding GAAP measures are not available without unreasonable efforts on a forward-looking basis due to our inability to predict specific quantifications of the amounts that would
be required to reconcile such measures.

-- 3 of 17 --

4
KEY FINANCIAL RESULTS
SECOND QUARTER FISCAL YEAR 2023 RESULTS
(1) Comparisons are to prior fiscal year period.
SECOND QUARTER (1) FIRST HALF (1)
Revenue $2.3 billion +9.2% $4.5 billion +11.1%
Revenue, Excluding Billable Expenses $1.6 billion +10.1% $3.2 billion +10.0%
Adjusted EBITDA $286 million +6.0% $539 million +6.1%
Adjusted EBITDA Margin on Revenue 12.4% (2.8)% 11.8% (4.5)%
Net Income $171 million +10.3% $309 million +25.1%
Adjusted Net Income $178 million +4.5% $329 million +4.0%
Diluted EPS $1.28 +12.3% $2.31 +27.6%
Adjusted Diluted EPS $1.34 +6.3% $2.47 +6.0%
Net Cash Provided by Operating Activities $273 million (42.0)% $227 million (50.6)%

-- 4 of 17 --

5

-- 5 of 17 --

6
KEY FINANCIAL RESULTS
SECOND QUARTER FISCAL YEAR 2023 RESULTS
(1) Comparisons are to prior fiscal year period.
SECOND QUARTER (1) FIRST HALF (1)
Revenue $2.3 billion +9.2% $4.5 billion +11.1%
Revenue, Excluding Billable Expenses $1.6 billion +10.1% $3.2 billion +10.0%
Adjusted EBITDA $286 million +6.0% $539 million +6.1%
Adjusted EBITDA Margin on Revenue 12.4% (2.8)% 11.8% (4.5)%
Net Income $171 million +10.3% $309 million +25.1%
Adjusted Net Income $178 million +4.5% $329 million +4.0%
Diluted EPS $1.28 +12.3% $2.31 +27.6%
Adjusted Diluted EPS $1.34 +6.3% $2.47 +6.0%
Net Cash Provided by Operating Activities $273 million (42.0)% $227 million (50.6)%
Page 4 intentionally repeated

-- 6 of 17 --

7
$22.0
HISTORICAL BACKLOG & BOOK-TO-BILL
(1) For more information on the components of backlog, and the differences between backlog and remaining performance obligations, please see the Company's Form 10-K for the fiscal year ended March 31, 2022; totals may not sum due
to rounding.
BACKLOG ($ IN BILLIONS) (1)
BOOK-TO-BILL TRENDS
$22.0 	$20.7 $23.0 	$24.6 	$23.3 	$24.0
$26.8 $29.0 	$27.8 	$29.2 	$28.6
$31.8
$3.5 	$3.4 	$3.4 	$4.5 	$3.6 	$3.5 	$3.5 	$4.9 	$4.0 	$3.7 	$4.0 	$5.5
$5.3 	$4.5 	$4.7 $6.2 	$6.0 	$6.1 	$9.0 $9.5 	$9.4 	$9.9 	$10.0 	$10.4
$13.1 	$12.8 	$14.8 $13.9 	$13.7 	$14.4
$14.3 $14.6 	$14.3 	$15.6 	$14.6 $16.0
Funded 	Unfunded 	Priced Options
3Q20 	4Q20 	1Q21 	2Q21 	3Q21 	4Q21 	1Q22 	2Q22 	3Q22 	4Q22 	1Q23 	2Q23
0.48x 	0.38x
2.17x
1.77x
0.32x
1.38x 	1.30x
2.03x
0.39x
1.66x
0.72x
2.40x
Quarterly Book-to-Bill 	LTM Book-to-Bill
3Q20 	4Q20 	1Q21 	2Q21 	3Q21 	4Q21 	1Q22 	2Q22 	3Q22 	4Q22 	1Q23 	2Q23
0.0x
1.0x
2.0x
3.0x
4.0x

-- 7 of 17 --

8
CAPITAL ALLOCATION
DELIVERING STRONG CAPITAL RETURNS THROUGH EFFICIENT CAPITAL DEPLOYMENT
STRATEGY
– Our multi-year capital deployment plan is to follow a disciplined and opportunistic approach, subject to market conditions
– In Q2 FY 2023, we deployed approximately $86.9 million:
– $57.0 million through quarterly dividends; and
– $29.9 million through share repurchases
– The Board authorized a dividend of $0.43 per share payable on December 2, 2022 to stockholders of record on November 15, 2022
– Increased total share repurchase authorization capacity by $400.0 million to $2.56 billion on July 27, 2022, $975.2 million available as of September 30,
2022
– Our capital allocation priorities remain: operating needs, quarterly dividend, strategic M&A, share repurchases, and debt repayment
HISTORICAL CAPITAL DEPLOYMENT ($ IN MILLIONS)(1)
QUARTERLY CAPITAL DEPLOYMENT ($ IN MILLIONS)(1)
$284.7
$138.8
$180.9
$116.5
$86.9
$50.2 	$49.8 	$57.4 	$58.9 	$57.0
$105.5 $82.8
$119.6
$57.6 $29.9
$128.9
$6.2
$4.0
$0.0
Quarterly Dividends 	Share Repurchases 	M&A
2Q22 	3Q22 	4Q22 	1Q23 	2Q23
$364.2 	$333.2
$571.3
$1,493.9
$523.0
$114.2 	$146.6 	$181.1 	$209.1 	$223.1
$250.0 	$186.6
$318.1 $419.3 $289.7
$72.2
$865.5
$10.2
Quarterly Dividends 	Share Repurchases 	M&A
FY19 	FY20 	FY21 	FY22 	LTM
(3)(4)
(1) Totals may not sum due to rounding.
(2) Includes share repurchases transacted but not settled and paid.
(3) Represents payments for strategic investments, net of cash acquired.
(4) Total amount of capital deployed for fiscal 2022 does not include ~$2 million in applicable fees related to our acquisition of Tracepoint.
(2) (3)(4) (2)

-- 8 of 17 --

9
FINANCIAL OUTLOOK
RAISING FULL YEAR FISCAL 2023 GUIDANCE
OPERATING PERFORMANCE Updated FY23 Guidance Original FY23 Guidance
Total Revenue Growth1 8.0 – 10.0% 5.0 – 9.0%
Adjusted EBITDA $975 – $1,015 million $950 – $1,000 million
Adjusted EBITDA Margin on Revenue High 10%-to-Low 11% Mid-to-High 10%
Adjusted Diluted EPS2 $4.25 – $4.50 $4.15 – $4.45
Net Cash Provided by Operating Activities3 $875 – $950 million $850 – $950 million
(1) Approximately 1% to 2% of the targeted growth in revenue includes Liberty, Tracepoint and EverWatch, partially offset by the MENA divestiture. Original guidance assumed inorganic contributions of approximately 1%.
(2) Assumes an effective tax rate of 23–25%; average diluted shares outstanding of 131–133 million, and interest expense of $117-122 million, while original guidance assumed interest expense of $108-$117 million.
(3) Excludes approximately $315 million of net cash taxes we expect to pay in fiscal 2023, as detailed on Slide 10.

-- 9 of 17 --

10
FISCAL YEAR 2023 OPERATING CASH BRIDGE
(1) Totals may not sum due to rounding.
(2) Adding back fiscal year 2022 cash tax payments to show an equal comparison to fiscal year 2023 Operating Cash Flow before cash tax payments.
(3) Reflects the expected impact of the midpoints of fiscal 2023 Adjusted EBITDA range of $975-1,015 million, interest expense range of $117-122 million, and effective tax rate range of 23-25 percent.
(4) Updated guidance reflects (i) cash taxes associated with tax law changes and strategic planning of $175 million, offset by (ii) a partial tax refund of $175 million received in October 2022 associated with prior strategic tax planning initiatives.
(5) Reflects the Company's refined estimate of cash to be paid in fiscal 2023 based upon current tax obligations relating to research and development expenditures.
Operating Cash
Bridge FY22 to FY23 Updated Guidance1 Original Guidance1
FY22 Operating Cash $737 million $737 million
FY22 Net Cash Paid for Income
Taxes2 $(127) million $(127) million
Adjusted EBITDA Growth3 ~$40 – $80 million ~$15 – $65 million
Interest Expense3 ~$(25) million ~$(16) million
Net Changes in Working Capital ~$(4) – $31 million ~$(14) – $37 million
FY23 Operating Cash Excluding Net
Cash to be Paid for Income Taxes $875 - $950 million $850 - $950 million
Effective Tax Rate3 ~$(175) million ~$(200) million
Tax Law Changes & Strategic
Planning4 $— ~$(200) million
Section 1745 ~$(140) million ~$(150) million
FY23 Operating Cash $560 - $635 million $300 - $400 million

-- 10 of 17 --

11
FISCAL YEAR 2023 ADEPS BRIDGE
ADEPS BRIDGE
FROM FY22 TO FY23 Updated Guidance1 Original Guidance1
FY22 ADEPS $4.21 $4.21
Revenue Growth ~$0.43 – $0.53 ~$0.28 – $0.48
Adjusted EBITDA Margin ~$(0.19) – $(0.05) ~$(0.20) – $(0.10)
FY23 Operational ADEPS $4.45 – $4.70 $4.29 – $4.59
Depreciation and Amortization2 ~$(0.03) ~$(0.02)
Interest Expense3 ~$(0.14) ~$(0.10)
Income Tax Expense4 ~$(0.06) ~$(0.05)
Other Below-the-Line Items5 ~$0.04 ~$0.05
FY23 ADEPS $4.25 – $4.50 $4.15 – $4.45
(1) Totals may not sum due to rounding.
(2) Reflects the incremental increase in depreciation and amortization related to investments in infrastructure and technology.
(3) Reflects the midpoint of the fiscal 2023 estimated interest expense range as compared to fiscal 2022 results.
(4) Reflects the midpoint of the fiscal 2023 estimated effective tax rate range as compared to fiscal 2022 results.
(5) Reflects the estimated interest income and lower average diluted shares outstanding from fiscal 2022 to fiscal 2023.

-- 11 of 17 --

12
APPENDIX

-- 12 of 17 --

13
NON-GAAP FINANCIAL INFORMATION
• "Revenue, Excluding Billable Expenses" represents revenue less billable expenses. We use Revenue, Excluding Billable Expenses because it
provides management useful information about the Company's operating performance by excluding the impact of costs that are not indicative of
the level of productivity of our client staff headcount and our overall direct labor, which management believes provides useful information to our
investors about our core operations.
• "Adjusted Operating Income" represents operating income before acquisition and divestiture costs, financing transaction costs, and significant
acquisition amortization. We prepare Adjusted Operating Income to eliminate the impact of items we do not consider indicative of ongoing
operating performance due to their inherent unusual, extraordinary, or non-recurring nature or because they result from an event of a similar
nature.
• "Adjusted EBITDA" represents net income attributable to common stockholders before income taxes, net interest and other expense and
depreciation and amortization and before certain other items, including acquisition and divestiture costs, financing transaction costs, restructuring
costs, and supplemental employee benefits due to COVID-19. “Adjusted EBITDA Margin on Revenue” is calculated as Adjusted EBITDA divided by
revenue. Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses is calculated as Adjusted EBITDA divided by Revenue, Excluding Billable
Expenses. We prepare Adjusted EBITDA, Adjusted EBITDA Margin on Revenue, and Adjusted EBITDA Margin on Revenue, Excluding Billable
Expenses to eliminate the impact of items it does not consider indicative of ongoing operating performance due to their inherent unusual,
extraordinary or non-recurring nature or because they result from an event of a similar nature.
• "Adjusted Net Income" represents net income attributable to common stockholders before: (i) acquisition and divestiture costs, (ii) financing
transaction costs, (iii) significant acquisition amortization, (iv) gain on consolidation of equity method investment, (v) amortization and write-off of
debt issuance costs and debt discount, and (vi) gain on sale or divestiture, in each case net of the tax effect where appropriate calculated using an
assumed effective tax rate. We prepare Adjusted Net Income to eliminate the impact of items, net of tax, we do not consider indicative of ongoing
operating performance due to their inherent unusual, extraordinary, or non-recurring nature or because they result from an event of a similar
nature. We view Adjusted Net Income as an important indicator of performance consistent with the manner in which management measures and
forecasts the Company's performance and the way in which management is incentivized to perform.
• "Adjusted Diluted EPS" represents diluted EPS calculated using Adjusted Net Income as opposed to net income. Additionally, Adjusted Diluted EPS
does not contemplate any adjustments to net income as required under the two-class method as disclosed in the footnotes to our consolidated
financial statements in our Form 10-K for the fiscal year ended March 31, 2022.
• "Free Cash Flow" represents the net cash generated from operating activities less the impact of purchases of property, equipment and software.
"Free Cash Flow Conversion" is calculated as Free Cash Flow divided by Adjusted Net Income.
• "Net Leverage Ratio" is calculated as net debt (total debt less cash) divided by Adjusted EBITDA over the prior twelve months.

-- 13 of 17 --

14
NON-GAAP FINANCIAL INFORMATION (Unaudited)
Three Months Ended
September 30, Six Months Ended
September 30,
(In thousands, except share and per share data) 2022 2021 2022 2021
Revenue, Excluding Billable Expenses
Revenue $ 2,298,976 $ 2,106,038 $ 4,548,576 $ 4,095,104
Less: Billable expenses 684,941 640,120 1,359,207 1,195,665
Revenue, Excluding Billable Expenses $ 1,614,035 $ 1,465,918 $ 3,189,369 $ 2,899,439
Adjusted Operating Income
Operating Income $ 223,921 $ 218,367 $ 431,116 $ 359,624
Acquisition and divestiture costs (a) 15,932 13,680 21,025 80,469
Financing transaction costs (b) 6,888 — 6,888 2,348
Significant acquisition amortization (c) 11,087 11,868 22,174 14,526
Adjusted Operating Income $ 257,828 $ 243,915 $ 481,203 $ 456,967
EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin on Revenue & Adjusted
EBITDA Margin on Revenue, Excluding Billable Expenses
Net income attributable to common stockholders 170,932 154,834 $ 309,216 $ 246,936
Income tax expense 51,258 46,127 92,747 73,479
Interest and other, net (d) 1,882 17,406 29,495 39,209
Depreciation and amortization 39,052 37,602 79,154 65,347
EBITDA 263,124 255,969 510,612 424,971
Acquisition and divestiture costs (a) 15,932 13,680 21,025 80,469
Financing transaction costs (b) 6,888 — 6,888 2,348
Adjusted EBITDA $ 285,944 $ 269,649 $ 538,525 $ 507,788
Adjusted EBITDA Margin on Revenue 12.4 % 12.8 % 11.8 % 12.4 %
Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses 17.7 % 18.4 % 16.9 % 17.5 %
Adjusted Net Income
Net income attributable to common stockholders $ 170,932 $ 154,834 $ 309,216 $ 246,936
Acquisition and divestiture costs (a) 15,932 13,680 21,025 80,469
Financing transaction costs (b) 6,888 — 6,888 2,348
Significant acquisition amortization (c) 11,087 11,868 22,174 14,526
Gain on consolidation of equity method investment (e) — (5,666) — (5,666)
Amortization and write-off of debt issuance costs and debt discount 4,177 816 5,000 1,703
Gain on sale or divestiture (f) (31,160) — (31,160) —
Adjustments for tax effect (g) (77) (5,381) (4,498) (24,279)
Adjusted Net Income $ 177,779 $ 170,151 $ 328,645 $ 316,037
Adjusted Diluted Earnings Per Share
Weighted-average number of diluted shares outstanding 132,729,245 135,316,429 132,869,141 135,847,548
Adjusted Net Income Per Diluted Share (h) $ 1.34 $ 1.26 $ 2.47 $ 2.33
Free Cash Flow
Net cash provided by operating activities $ 272,726 $ 470,408 $ 227,092 $ 459,746
Less: Purchases of property, equipment, and software (16,000) (20,667) (29,734) (29,675)
Free Cash Flow $ 256,726 $ 449,741 $ 197,358 $ 430,071
Free Cash Flow Conversion 144 % 264 % 60 % 136 % 14

-- 14 of 17 --

15
NON-GAAP FINANCIAL INFORMATION (Unaudited)
(a) Represents costs associated with the acquisition efforts of the Company related to transactions for which the Company has entered into a letter of
intent to acquire a controlling financial interest in the target entity, as well as the divestiture costs incurred in divesting a portion of our business.
Acquisition and divestiture costs primarily include costs associated with (i) buy-side and sell-side due diligence activities, (ii) compensation expenses
associated with employee retention, and (iii) legal and advisory fees primarily associated with the acquisitions of Liberty IT Solutions, LLC ("Liberty"),
Tracepoint Holdings, LLC ("Tracepoint"), and EverWatch Corp. ("EverWatch"), as well as the divestiture of our management consulting business serving
the Middle East and North Africa (the "MENA Divestiture").
(b) Reflects expenses associated with debt financing activities incurred during the first quarter of fiscal 2022 and the second quarter of fiscal 2023.
(c) Amortization expense associated with acquired intangibles from significant acquisitions. Significant acquisitions include acquisitions which the
Company considers to be beyond the scope of our normal operations. Significant acquisition amortization includes amortization expense associated with
the acquisition of Liberty in the first quarter of fiscal 2022.
(d) Reflects the combination of Interest expense and Other income, net from the condensed consolidated statement of operations.
(e) Represents the Company's remeasurement of its previously held equity method investment in Tracepoint to its fair value which resulted in a gain
upon the acquisition of a controlling financial interest in Tracepoint.
(f) Represents the gain recognized on the MENA Divestiture.
(g) Reflects the tax effect of adjustments, except the gain on sale of divestiture, at an assumed effective tax rate of 26%, which approximates the
blended federal and state tax rates, and consistently excludes the impact of other tax credits and incentive benefits realized. The tax effect of the gain on
sale or divestiture is at an assumed effective tax rate of 32%.
(h) Excludes adjustments of approximately $1.4 million and $2.3 million of net earnings for the three and six months ended September 30, 2022,
respectively and excludes adjustments of approximately $1.1 million and $1.5 million of net earnings for the three and six months ended September 30,
2021, respectively, associated with the application of the two-class method for computing diluted earnings per share.
15

-- 15 of 17 --

16
NON-GAAP FINANCIAL INFORMATION (Unaudited)
(In thousands, except share and per share data) Three Months Ended
September 30, 2022 Three Months Ended
June 30, 2022 Three Months Ended
March 31, 2022 Three Months Ended
December 31, 2021
Net income attributable to common stockholders $ 170,932 $ 138,284 $ 90,795 $ 128,846
Income tax expense 51,258 41,489 33,897 30,090
Interest and other, net (a) 1,882 27,613 23,653 18,276
Depreciation and amortization 39,052 40,102 40,824 39,576
EBITDA $ 263,124 $ 247,488 $ 189,169 $ 216,788
Acquisition and divestiture costs (b) 15,932 5,093 11,670 5,346
Financing transaction costs (c) 6,888
Restructuring costs (d) — — 4,164 —
Adjusted EBITDA $ 285,944 $ 252,581 $ 205,003 $ 222,134
Last 12 months Adjusted EBITDA $ 965,662
Total Debt $ 2,831,261
Less: Cash 756,520
Net Debt $ 2,074,741
Net Leverage Ratio 2.1
Three Months Ended
September 30, 2021 Three Months Ended
June 30, 2021 Three Months Ended
March 31, 2021 Three Months Ended
December 31, 2020
Net income attributable to common stockholders $ 154,834 $ 92,102 $ 199,179 $ 144,371
Income tax expense 46,127 27,352 (48,937) 21,612
Interest and other, net (a) 17,406 21,803 20,765 18,274
Depreciation and amortization 37,602 27,745 21,455 21,113
EBITDA $ 255,969 $ 169,002 $ 192,462 $ 205,370
Acquisition and divestiture costs (b) 13,680 66,789 411 —
Financing transaction costs (c) — 2,348 — —
COVID-19 supplemental employee benefits (e) — — — 68
Adjusted EBITDA $ 269,649 $ 238,139 $ 192,873 $ 205,438
Last 12 months Adjusted EBITDA $ 906,099
Total Debt $ 2,832,462
Less: Cash 788,697
Net Debt $ 2,043,765
Net Leverage Ratio 2.3
16
(a) Reflects the combination of Interest
expense and Other income, net from the
condensed consolidated statement of
operations.
(b) Represents costs associated with the
Company's acquisition efforts related to
transactions for which the Company has
entered into a letter of intent to acquire
a controlling financial interest in the
target entity, as well as the divestiture
costs incurred in divesting a portion of
our business. Acquisition and divestiture
costs primarily include costs associated
with (i) buy-side and sell-side due
diligence activities, (ii) compensation
expenses associated with employee
retention, and (iii) legal and advisory
fees primarily associated with the
acquisitions of Liberty, Tracepoint, and
EverWatch, as well as the MENA
Divestiture.
(c) Reflects expenses associated with
debt financing activities incurred during
the first quarter of fiscal 2022 and the
second quarter of fiscal 2023.
(d) Reflects restructuring charges of $8.3
million incurred during the fourth
quarter of fiscal 2022, net of
approximately $4.2 million of revenue
recognized on recoverable expenses,
associated with severance costs of a
restructuring plan to reduce certain
executive administrative personnel
costs.
(e) Represents the supplemental
contribution to employees' dependent
care FSA accounts in response to
COVID-19.

-- 16 of 17 --

17
FINANCIAL RESULTS – KEY DRIVERS
Second Quarter Fiscal 2023 – Below is a summary of the key factors driving results for the fiscal 2023 second quarter ended
September 30, 2022 as compared to the prior year period:
• Revenue increased 9.2% to $2.3 billion and Revenue, Excluding Billable Expenses increased 10.1% to $1.6 billion. Revenue growth was
primarily driven by a combination of headcount growth, salary increases, and strong demand for our solutions, as well as higher staff
utilization as compared to the prior year period.
• Operating income increased 2.5% to $223.9 million and Adjusted Operating Income increased 5.7% to $257.8 million. These increases
were primarily driven by the same drivers benefiting revenue growth, coupled with ongoing cost management efforts. Operating
income was negatively impacted by $6.9 million in debt issuance costs related to the Company's September 2022 debt refinancing
and $2.3 million of additional acquisition and divestiture costs compared to the comparable prior year period, both of which did not
impact Adjusted Operating Income.
• Net income increased 10.3% to $170.8 million, and net income attributable to common stockholders increased 10.4% to $170.9
million. These changes were primarily driven by the same factors as operating income, as well as a $31.2 million pre-tax gain from the
sale of the Company's MENA business, partially offset by higher interest expense. Adjusted Net income increased 4.5% to $177.8
million. The change in Adjusted Net Income was primarily driven by the same factors as Adjusted Operating Income, partially offset by
a higher interest expense.
• EBITDA increased 2.8% to $263.1 million and Adjusted EBITDA increased 6.0% to $285.9 million.These changes were due to the same
factors as operating income and Adjusted Operating Income, respectively.
• Diluted EPS increased to $1.28 from $1.14 and Adjusted Diluted EPS increased to $1.34 from $1.26. The changes were primarily
driven by the same factors as Net Income and Adjusted Net Income, respectively, partially offset by a lower share count in the second
quarter of fiscal 2023.
• Net cash provided by operating activities was $272.7 million for the quarter ended September 30, 2022, as compared to $470.4
million in the prior year period. Free Cash Flow was $256.7 million for the three months ended September 30, 2022, as compared to
$449.7 million in the prior year period. Cash provided by operating activities and Free Cash Flow benefited from our strong operating
performance, which were partially offset by higher cash taxes paid.

-- 17 of 17 --